Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database
Abstract Background In this study, we aimed to investigate the association between postoperative radiotherapy (PORT) and cardiac‐related mortality in patients with stage IIIA‐N2 non‐small cell lung cancer (NSCLC) using the Surveillance, Epidemiology, and End Results (SEER) database. Methods The Unit...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.13908 |
id |
doaj-22eb1c12f0dc4c7b9fd34054a348c066 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xin Sun Yu Men Jianyang Wang Yongxing Bao Xu Yang Maoyuan Zhao Shuang Sun Meng Yuan Zeliang Ma Zhouguang Hui |
spellingShingle |
Xin Sun Yu Men Jianyang Wang Yongxing Bao Xu Yang Maoyuan Zhao Shuang Sun Meng Yuan Zeliang Ma Zhouguang Hui Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database Thoracic Cancer cardiac‐related mortality non‐small cell lung cancer postoperative radiotherapy stage IIIA‐N2 |
author_facet |
Xin Sun Yu Men Jianyang Wang Yongxing Bao Xu Yang Maoyuan Zhao Shuang Sun Meng Yuan Zeliang Ma Zhouguang Hui |
author_sort |
Xin Sun |
title |
Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database |
title_short |
Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database |
title_full |
Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database |
title_fullStr |
Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database |
title_full_unstemmed |
Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database |
title_sort |
risk of cardiac‐related mortality in stage iiia‐n2 non‐small cell lung cancer: analysis of the surveillance, epidemiology, and end results (seer) database |
publisher |
Wiley |
series |
Thoracic Cancer |
issn |
1759-7706 1759-7714 |
publishDate |
2021-05-01 |
description |
Abstract Background In this study, we aimed to investigate the association between postoperative radiotherapy (PORT) and cardiac‐related mortality in patients with stage IIIA‐N2 non‐small cell lung cancer (NSCLC) using the Surveillance, Epidemiology, and End Results (SEER) database. Methods The United States (US) population based on the SEER database was searched for cardiac‐related mortality among patients with stage IIIA‐N2 NSCLC. Cardiac‐related mortality was compared between the PORT and Non‐PORT groups. Accounting for mortality from other causes, Fine and Gray's test compared cumulative incidences of cardiac‐related mortality between both groups. Univariate and multivariate analysis were performed using the competing risk model. Results From 1988 to 2016, 7290 patients met the inclusion criteria: 3386 patients were treated with PORT and 3904 patients with Non‐PORT. The five‐year overall incidence of cardiac‐related mortality was 3.01% in the PORT group and 3.26% in the Non‐PORT group. Older age, male sex, squamous cell lung cancer, earlier year of diagnosis and earlier T stage were independent adverse factors for cardiac‐related mortality. However, PORT use was not associated with an increase in the hazard for cardiac‐related mortality (subdistribution hazard ratio [SHR] = 0.99, 95% confidence interval [CI]: 0.78–1.24, p = 0.91). When evaluating cardiac‐related mortality in each time period, the overall incidence of cardiac‐related mortality was decreased over time. There were no statistically significant differences based on PORT use in all time periods. Conclusions With a median follow‐up of 25 months, no significant differences were found in cardiac‐related mortality between the PORT and Non‐PORT groups in stage IIIA‐N2 NSCLC patients. |
topic |
cardiac‐related mortality non‐small cell lung cancer postoperative radiotherapy stage IIIA‐N2 |
url |
https://doi.org/10.1111/1759-7714.13908 |
work_keys_str_mv |
AT xinsun riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase AT yumen riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase AT jianyangwang riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase AT yongxingbao riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase AT xuyang riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase AT maoyuanzhao riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase AT shuangsun riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase AT mengyuan riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase AT zeliangma riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase AT zhouguanghui riskofcardiacrelatedmortalityinstageiiian2nonsmallcelllungcanceranalysisofthesurveillanceepidemiologyandendresultsseerdatabase |
_version_ |
1721486480365322240 |
spelling |
doaj-22eb1c12f0dc4c7b9fd34054a348c0662021-05-02T23:54:27ZengWileyThoracic Cancer1759-77061759-77142021-05-011291358136510.1111/1759-7714.13908Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) databaseXin Sun0Yu Men1Jianyang Wang2Yongxing Bao3Xu Yang4Maoyuan Zhao5Shuang Sun6Meng Yuan7Zeliang Ma8Zhouguang Hui9Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaAbstract Background In this study, we aimed to investigate the association between postoperative radiotherapy (PORT) and cardiac‐related mortality in patients with stage IIIA‐N2 non‐small cell lung cancer (NSCLC) using the Surveillance, Epidemiology, and End Results (SEER) database. Methods The United States (US) population based on the SEER database was searched for cardiac‐related mortality among patients with stage IIIA‐N2 NSCLC. Cardiac‐related mortality was compared between the PORT and Non‐PORT groups. Accounting for mortality from other causes, Fine and Gray's test compared cumulative incidences of cardiac‐related mortality between both groups. Univariate and multivariate analysis were performed using the competing risk model. Results From 1988 to 2016, 7290 patients met the inclusion criteria: 3386 patients were treated with PORT and 3904 patients with Non‐PORT. The five‐year overall incidence of cardiac‐related mortality was 3.01% in the PORT group and 3.26% in the Non‐PORT group. Older age, male sex, squamous cell lung cancer, earlier year of diagnosis and earlier T stage were independent adverse factors for cardiac‐related mortality. However, PORT use was not associated with an increase in the hazard for cardiac‐related mortality (subdistribution hazard ratio [SHR] = 0.99, 95% confidence interval [CI]: 0.78–1.24, p = 0.91). When evaluating cardiac‐related mortality in each time period, the overall incidence of cardiac‐related mortality was decreased over time. There were no statistically significant differences based on PORT use in all time periods. Conclusions With a median follow‐up of 25 months, no significant differences were found in cardiac‐related mortality between the PORT and Non‐PORT groups in stage IIIA‐N2 NSCLC patients.https://doi.org/10.1111/1759-7714.13908cardiac‐related mortalitynon‐small cell lung cancerpostoperative radiotherapystage IIIA‐N2 |